Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma
- PMID: 26112097
- DOI: 10.1016/j.yexmp.2015.06.017
Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma
Abstract
As a transcriptional repressor, forkhead box D3 (FOXD3) plays an important role in tumorigenesis and progression of several tumors. However, the function and methylation status of FOXD3 remain unknown in the progression of hepatocellular carcinoma (HCC). In this study, we found that FOXD3 was decreased in HCC tissues and correlated with differentiation, AFP and poor survival of HCC patients (p<0.05). Down-regulation of FOXD3 in HCC tissues was mainly due to promoter hypermethylation. In vitro and in vivo functional results showed that ectopic FOXD3 inhibited the proliferation, migration, epithelial-mesenchymal transition (EMT) and invasion in HepG2 and SMMC-7721 cells, and FOXD3 depletion in HepG2 and QGY-7701 cells showed the adverse effects (p<0.05). Moreover, FOXD3 was sufficient to suppress tumor growth and pulmonary metastatic potential in mice. Our findings suggest that down-regulation of FOXD3, due to promoter hypermethylation plays an important role in the progression of HCC and may be a promising prognostic biomarker for HCC patients.
Keywords: FOXD3; Hepatocellular carcinoma; Invasion; Metastasis; Methylation.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.Oncotarget. 2015 Nov 10;6(35):37808-23. doi: 10.18632/oncotarget.5676. Oncotarget. 2015. PMID: 26498692 Free PMC article.
-
Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.Oncotarget. 2015 Dec 1;6(38):40622-41. doi: 10.18632/oncotarget.5872. Oncotarget. 2015. PMID: 26536663 Free PMC article. Clinical Trial.
-
RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.Oncotarget. 2016 Jan 26;7(4):4279-97. doi: 10.18632/oncotarget.6654. Oncotarget. 2016. PMID: 26701853 Free PMC article.
-
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):361-6. doi: 10.1016/s1499-3872(15)60396-4. Hepatobiliary Pancreat Dis Int. 2015. PMID: 26256079 Review.
-
Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.Life Sci. 2019 Aug 15;231:116660. doi: 10.1016/j.lfs.2019.116660. Epub 2019 Jul 15. Life Sci. 2019. PMID: 31319086 Review.
Cited by
-
The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.Br J Cancer. 2016 Nov 22;115(11):1367-1378. doi: 10.1038/bjc.2016.362. Epub 2016 Nov 3. Br J Cancer. 2016. PMID: 27811858 Free PMC article.
-
ASMdb: a comprehensive database for allele-specific DNA methylation in diverse organisms.Nucleic Acids Res. 2022 Jan 7;50(D1):D60-D71. doi: 10.1093/nar/gkab937. Nucleic Acids Res. 2022. PMID: 34664666 Free PMC article.
-
Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1.FEBS Open Bio. 2016 Oct 24;6(12):1211-1219. doi: 10.1002/2211-5463.12135. eCollection 2016 Dec. FEBS Open Bio. 2016. PMID: 28203521 Free PMC article.
-
FOXD3 controls pluripotency through modulating enhancer activity.Stem Cell Investig. 2016 May 27;3:17. doi: 10.21037/sci.2016.05.03. eCollection 2016. Stem Cell Investig. 2016. PMID: 27488581 Free PMC article. No abstract available.
-
Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors.Endocr Relat Cancer. 2023 Sep 11;30(10):e230067. doi: 10.1530/ERC-23-0067. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37578265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials